White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn’s Disease

Not recruiting

3 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Guselkumab
+5
Study on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients

Not recruiting

3 1 1 1 1
Investigated diseases:
- Neuralgia
Investigated drugs:
- Capsaicin
Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

Not recruiting

3 1 1 1
Investigated diseases:
- Staphylococcal bacteraemia
Investigated drugs:
Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Long-Term Safety and Effectiveness of Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Not recruiting

3 1 1
Investigated diseases:
- Hypertension
Investigated drugs:
- Lorundrostat
- Tetracosactide
+2
Study on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy

Not recruiting

1 1 1
Investigated diseases:
- Hereditary neuropathic amyloidosis
Investigated drugs:
- Single Guide Rna Targeting The Human Ttr Gene
- Ziclumeran
Study of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on Sodium Zirconium Cyclosilicate for Improving Heart Failure Treatment in Patients with High-Risk Hyperkalemia

Not recruiting

2 1 1
Investigated drugs:
- Sodium Zirconium Cyclosilicate
Study of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+3
Study of venetoclax and azacitidine combination treatment for acute myeloid leukemia patients with measurable residual disease after chemotherapy or before stem cell transplant

Not recruiting

4 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Azacitidine
- Venetoclax

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies